Not really. Just a small trickle from bank interest, a bit from R and D grant and then a small amount from selling some product to the government for research purposes. Nothing recurrent and nothing that would mean the company is producing finished dose form.
where to next?, page-871
-
- There are more pages in this discussion • 312 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
